FR2387035B1 - - Google Patents

Info

Publication number
FR2387035B1
FR2387035B1 FR7710906A FR7710906A FR2387035B1 FR 2387035 B1 FR2387035 B1 FR 2387035B1 FR 7710906 A FR7710906 A FR 7710906A FR 7710906 A FR7710906 A FR 7710906A FR 2387035 B1 FR2387035 B1 FR 2387035B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7710906A
Other languages
French (fr)
Other versions
FR2387035A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7710906A priority Critical patent/FR2387035A1/fr
Priority to IL54462A priority patent/IL54462A0/xx
Priority to JP4135578A priority patent/JPS53130440A/ja
Priority to BE186726A priority patent/BE865891A/xx
Priority to GB14173/78A priority patent/GB1556851A/en
Priority to GR55954A priority patent/GR72116B/el
Priority to PT67885A priority patent/PT67885B/pt
Priority to IT48852/78A priority patent/IT1102581B/it
Priority to NL7803895A priority patent/NL7803895A/xx
Priority to DE2815878A priority patent/DE2815878C2/de
Publication of FR2387035A1 publication Critical patent/FR2387035A1/fr
Application granted granted Critical
Publication of FR2387035B1 publication Critical patent/FR2387035B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7710906A 1977-04-12 1977-04-12 Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux Granted FR2387035A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7710906A FR2387035A1 (fr) 1977-04-12 1977-04-12 Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
IL54462A IL54462A0 (en) 1977-04-12 1978-04-06 Pharmaceutical compositions intended especially for the treatment of functional disorders of the brain, comprising purine derivatives
JP4135578A JPS53130440A (en) 1977-04-12 1978-04-10 Novel pharmaceutical composition having obuect to treat especially functional disorder of brain
GB14173/78A GB1556851A (en) 1977-04-12 1978-04-11 Pharmaceutical compositions
BE186726A BE865891A (fr) 1977-04-12 1978-04-11 Nouvelles compositions pharmaceutiques destine notamment au traitement des troubles fonctionnels cerebraux
GR55954A GR72116B (ja) 1977-04-12 1978-04-11
PT67885A PT67885B (fr) 1977-04-12 1978-04-11 Tiques destinees notamment au traitement des troubles fonc
IT48852/78A IT1102581B (it) 1977-04-12 1978-04-11 Composizioni farmaceutiche particolarmente utili nella cura di turbe funzionali cerebrali
NL7803895A NL7803895A (nl) 1977-04-12 1978-04-12 Nieuwe farmaceutische preparaten, in het bijzonder be- stemd voor de behandeling van funktionele cerebrale stoornissen.
DE2815878A DE2815878C2 (de) 1977-04-12 1978-04-12 Pharmazeutische Zusammensetzungen auf der Basis von 1,3-Dimethyl-3,7-dihydro-7-(5'-oxo-hexyl)-IH-purin-2,6-dion und Dihydroergocristin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7710906A FR2387035A1 (fr) 1977-04-12 1977-04-12 Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux

Publications (2)

Publication Number Publication Date
FR2387035A1 FR2387035A1 (fr) 1978-11-10
FR2387035B1 true FR2387035B1 (ja) 1980-03-21

Family

ID=9189287

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7710906A Granted FR2387035A1 (fr) 1977-04-12 1977-04-12 Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux

Country Status (10)

Country Link
JP (1) JPS53130440A (ja)
BE (1) BE865891A (ja)
DE (1) DE2815878C2 (ja)
FR (1) FR2387035A1 (ja)
GB (1) GB1556851A (ja)
GR (1) GR72116B (ja)
IL (1) IL54462A0 (ja)
IT (1) IT1102581B (ja)
NL (1) NL7803895A (ja)
PT (1) PT67885B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
FI81258C (fi) * 1982-02-01 1990-10-10 Sandoz Ag Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment

Also Published As

Publication number Publication date
PT67885B (fr) 1980-04-07
FR2387035A1 (fr) 1978-11-10
DE2815878A1 (de) 1978-10-19
IT1102581B (it) 1985-10-07
PT67885A (fr) 1978-05-01
GR72116B (ja) 1983-09-15
IT7848852A0 (it) 1978-04-11
DE2815878C2 (de) 1986-10-09
NL7803895A (nl) 1978-10-16
BE865891A (fr) 1978-10-11
JPS627167B2 (ja) 1987-02-16
IL54462A0 (en) 1978-07-31
JPS53130440A (en) 1978-11-14
GB1556851A (en) 1979-11-28

Similar Documents

Publication Publication Date Title
DE2815520C2 (ja)
FR2377041B1 (ja)
DE2804362C3 (ja)
DE2853618C2 (ja)
DE2723099C2 (ja)
DE2746956C2 (ja)
DE2811068C3 (ja)
DK153277A (ja)
JPS542298U (ja)
BG25839A1 (ja)
BG25826A1 (ja)
BG25819A1 (ja)
BG25860A1 (ja)
BG25855A1 (ja)
BG25853A1 (ja)
BG25852A1 (ja)
BG25851A1 (ja)
BG25850A1 (ja)
BG25848A1 (ja)
BG25847A1 (ja)
BG25845A1 (ja)
BG25844A1 (ja)
BG25841A1 (ja)
BG25840A1 (ja)
CH614476A5 (ja)